Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
出版年份 2020 全文链接
标题
Tumor- and mitochondria-targeted nanoparticles eradicate drug resistant lung cancer through mitochondrial pathway of apoptosis
作者
关键词
-
出版物
JOURNAL OF NANOBIOTECHNOLOGY
Volume 18, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-01-09
DOI
10.1186/s12951-019-0562-3
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Small-molecule allosteric inhibitors of BAX
- (2019) Thomas P. Garner et al. Nature Chemical Biology
- A non‐death function of the mitochondrial apoptosis apparatus in immunity
- (2019) Dominik Brokatzky et al. EMBO JOURNAL
- Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells
- (2019) Ji Hee Kang et al. Pharmaceutics
- Preparation of injectable temperature-sensitive chitosan-based hydrogel for combined hyperthermia and chemotherapy of colon cancer
- (2019) Yuting Zheng et al. CARBOHYDRATE POLYMERS
- MiR-193a-5p and -3p Play a Distinct Role in Gastric Cancer: miR-193a-3p Suppresses Gastric Cancer Cell Growth by Targeting ETS1 and CCND1
- (2018) NAN-HUA CHOU et al. ANTICANCER RESEARCH
- LysoTracker and MitoTracker Red are transport substrates of P-glycoprotein: implications for anticancer drug design evading multidrug resistance
- (2018) Benny Zhitomirsky et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Theranostic size-reducible and no donor conjugated gold nanocluster fabricated hyaluronic acid nanoparticle with optimal size for combinational treatment of breast cancer and lung metastasis
- (2018) Rui Liu et al. JOURNAL OF CONTROLLED RELEASE
- Targeted production of reactive oxygen species in mitochondria to overcome cancer drug resistance
- (2018) Hai Wang et al. Nature Communications
- Preparation and evaluation of tumour microenvironment response multistage nanoparticles for epirubicin delivery and deep tumour penetration
- (2018) Jialing Dai et al. Artificial Cells Nanomedicine and Biotechnology
- Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells
- (2017) Ankit Saneja et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Intermediate Molecular Mass Hyaluronan and CD44 Receptor Interactions Enhance Neutrophil Phagocytosis and IL-8 Production via p38- and ERK1/2-MAPK Signalling Pathways
- (2017) Cheng-Hsun Lu et al. INFLAMMATION
- pH-Sensitive Nano-Complexes Overcome Drug Resistance and Inhibit Metastasis of Breast Cancer by Silencing Akt Expression
- (2017) Jieying Yin et al. Theranostics
- Aminoglucose-functionalized, redox-responsive polymer nanomicelles for overcoming chemoresistance in lung cancer cells
- (2017) Yi Zhou et al. JOURNAL OF NANOBIOTECHNOLOGY
- Myocardial oxidative damage is induced by cardiac Fas-dependent and mitochondria-dependent apoptotic pathways in human cocaine-related overdose
- (2017) Emanuela Turillazzi et al. Scientific Reports
- Synergistic active targeting of dually integrin α v β 3 /CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies
- (2016) Sanjun Shi et al. JOURNAL OF CONTROLLED RELEASE
- The CD44-Mediated Uptake of Hyaluronic Acid-Based Carriers in Macrophages
- (2016) Julio M. Rios de la Rosa et al. Advanced Healthcare Materials
- Dual Drug Conjugated Nanoparticle for Simultaneous Targeting of Mitochondria and Nucleus in Cancer Cells
- (2015) Abhik Mallick et al. ACS Applied Materials & Interfaces
- The multifaceted mitochondrion: An attractive candidate for therapeutic strategies
- (2015) Flavie Strappazzon et al. PHARMACOLOGICAL RESEARCH
- The energy blocker inside the power house: mitochondria targeted delivery of 3-bromopyruvate
- (2015) Sean Marrache et al. Chemical Science
- Doxorubicin loaded singlet-oxygen producible polymeric micelle based on chlorine e6 conjugated pluronic F127 for overcoming drug resistance in cancer
- (2014) Hyung Park et al. BIOMATERIALS
- Enhanced Antitumor Efficacy by d-Glucosamine-Functionalized and Paclitaxel-Loaded Poly(Ethylene Glycol)-Co-Poly(Trimethylene Carbonate) Polymer Nanoparticles
- (2014) Xinyi Jiang et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Detouring of cisplatin to access mitochondrial genome for overcoming resistance
- (2014) S. Marrache et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer
- (2013) Jia Zhou et al. BIOMATERIALS
- Conjugation of the photosensitizer Chlorin e6 to pluronic F127 for enhanced cellular internalization for photodynamic therapy
- (2013) Hyung Park et al. BIOMATERIALS
- Enhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatin
- (2013) Sia Lee Yoong et al. BIOMATERIALS
- Minimizing the damage: repair pathways keep mitochondrial DNA intact
- (2012) Lawrence Kazak et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Mechanisms of Endocytosis
- (2009) Gary J. Doherty et al. Annual Review of Biochemistry
- Pharmacodynamics of cisplatin-loaded PLGA nanoparticles administered to tumor-bearing mice
- (2009) Daniel Moreno et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
- Ring-Opening Polymerization-Mediated Controlled Formulation of Polylactide−Drug Nanoparticles
- (2009) Rong Tong et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Controlling Plasma Protein Binding: Structural Correlates of Interactions of Hydrophobic Polyamine Endotoxin Sequestrants with Human Serum Albumin
- (2008) Thuan B. Nguyen et al. MOLECULAR PHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started